Literature DB >> 1714475

Suppressive effects of monocytic cells and transforming growth factor-beta on natural killer cell differentiation in autoimmune viable motheaten mutant mice.

G C Koo1, C L Manyak, J Dasch, L Ellingsworth, L D Shultz.   

Abstract

Viable motheaten (mev) mice are homozygous for a recessive single gene mutation at chromosome 6. These mice develop numerous inflammatory and arthritic syndromes and exhibit abnormal B cell functions as well as lower T and NK cell activity. In this study, the differentiation of NK cells in mev mice was examined to elucidate the underlying basis for decreased NK activity. Although NK cells appear to be present in mev mice, their activity was demonstrable only when the spleen cells were enriched by nylon wool passage. Similarly bone marrow cells from these mice could be shown to contain precursors of NK cells when they were passed over nylon wool and transplanted into irradiated recipients. The adherent cells from both the spleen and bone marrow of mev mice suppressed the differentiation of NK cells from normal splenic populations. These suppressive adherent cells were F4/80(+), AsGm-1(+), Qa-5(+), and NK-1.1(+). They were not cytolytic when cultured in IL-2. Antibodies to a number of cytokines, such as IFN-alpha, -beta, and gamma, or TNF-alpha, could not reverse the suppressive effect of the adherent cells. Addition of anti-TGF-beta antibody could, however, overcome the suppression, suggesting that TGF-beta was partly responsible for the defective NK differentiation in the mev mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714475

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness.

Authors:  U Lorenz; K S Ravichandran; S J Burakoff; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice.

Authors:  R S Thrall; S N Vogel; R Evans; L D Shultz
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 3.  Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1.

Authors:  Florence W L Tsui; Alberto Martin; John Wang; Hing Wo Tsui
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice.

Authors:  I Mlinaric-Rascan; S L Asa; K A Siminovitch
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 5.  Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.

Authors:  Tanuja Chitnis; Samia J Khoury
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 6.  Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.

Authors:  S M Wahl
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

7.  Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis.

Authors:  D Ma; J Y Niederkorn
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

8.  B and T cells are not required for the viable motheaten phenotype.

Authors:  C C Yu; H W Tsui; B Y Ngan; M J Shulman; G E Wu; F W Tsui
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase.

Authors:  M C Nakamura; E C Niemi; M J Fisher; L D Shultz; W E Seaman; J C Ryan
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

10.  SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing.

Authors:  Sajid Mahmood; Namita Kanwar; Jimmy Tran; Man-Li Zhang; Sam K P Kung
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.